Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.34 USD | +7.74% | +6.03% | +3.73% |
Apr. 29 | HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target | MT |
Mar. 08 | Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 12.81M | Sales 2025 * | 46.35M | Capitalization | 237M |
---|---|---|---|---|---|
Net income 2024 * | -51M | Net income 2025 * | -23M | EV / Sales 2024 * | 18.5 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.1 x |
P/E ratio 2024 * |
-4.75
x | P/E ratio 2025 * |
-11.5
x | Employees | 40 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.03% |
Latest transcript on Ovid Therapeutics Inc.
1 day | +7.74% | ||
1 week | +6.03% | ||
Current month | +9.51% | ||
1 month | +9.51% | ||
3 months | -13.02% | ||
6 months | +2.14% | ||
Current year | +3.73% |
Managers | Title | Age | Since |
---|---|---|---|
Jeremy Levin
CEO | Chief Executive Officer | 70 | 14-03-31 |
Jeffrey Rona
DFI | Director of Finance/CFO | 55 | 18-12-31 |
Zhong Zhong
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barbara Duncan
BRD | Director/Board Member | 59 | 17-06-13 |
Bart Friedman
BRD | Director/Board Member | 79 | 15-11-22 |
Jeremy Levin
CEO | Chief Executive Officer | 70 | 14-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.43% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 3.34 | +7.74% | 311,343 |
24-04-26 | 3.1 | +3.68% | 80,529 |
24-04-25 | 2.99 | -5.08% | 112,117 |
24-04-24 | 3.15 | -1.56% | 113,127 |
24-04-23 | 3.2 | +1.59% | 110,579 |
Delayed Quote Nasdaq, April 29, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.73% | 237M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.92% | 22.18B | |
-16.67% | 21.2B | |
-9.23% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- OVID Stock